XKRX007390
Market cap886mUSD
Dec 24, Last price
20,300.00KRW
1D
1.00%
1Q
106.51%
Jan 2017
336.09%
Name
NatureCell Co Ltd
Chart & Performance
P/E
—
P/S
66.78
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
2.30%
Rev. gr., 5y
-6.25%
Revenues
19.35b
-8.95%
Net income
-11.68b
L+13.81%
CFO
-2.13b
L-85.68%
Earnings
Mar 28, 2025
Profile
NatureCell Co.,Ltd. manufactures and sells canned and health functional food products, beverages, stem cell, and cosmetics in South Korea and internationally. The company's products comprise fruit drinks, aloe vera drinks, coffee, energy drinks, and Korean sauces, as well as offers domestic products and ETC products under the SAMMI and OEM brands. It also provides services for the preservation of blood cells, such as endothelial progenitor cells, mononuclear cells, and platelet rich plasma products. The company was formerly known as RNL Sammi CO., Ltd. and changed its name to NatureCell Co.,Ltd. in April 2013. NatureCell Co.,Ltd. was founded in 1960 and is based in Seoul, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 19,350,887 -8.95% | 21,252,018 4.41% | 20,354,394 21.74% | |||||
Cost of revenue | 23,338,405 | 25,014,776 | 24,258,963 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | (3,987,518) | (3,762,758) | (3,904,569) | |||||
NOPBT Margin | ||||||||
Operating Taxes | (132,641) | 2,463,962 | 2,376,410 | |||||
Tax Rate | ||||||||
NOPAT | (3,854,877) | (6,226,719) | (6,280,980) | |||||
Net income | (11,680,329) 13.81% | (10,263,133) -67.96% | (32,030,755) 69.75% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 16,031,150 | 10,650 | 1,761,115 | |||||
BB yield | -3.16% | 0.00% | -0.16% | |||||
| Debt | ||||||||
Debt current | 866,148 | 24,851,444 | 1,176,435 | |||||
Long-term debt | 3,763,786 | 1,359,617 | 2,723,569 | |||||
Deferred revenue | ||||||||
Other long-term liabilities | 1,316,440 | 430,575 | 864,554 | |||||
Net debt | (31,750,465) | (14,521,769) | (38,742,372) | |||||
| Cash flow | ||||||||
Cash from operating activities | (2,128,245) | (14,865,600) | (10,149,935) | |||||
CAPEX | (6,124,318) | (3,795,010) | (455,395) | |||||
Cash from investing activities | 15,578,944 | (15,334,814) | 4,823,128 | |||||
Cash from financing activities | (14,935,147) | 29,070,795 | (3,709,519) | |||||
FCF | 9,907,195 | (27,358,755) | (10,426,061) | |||||
| Balance | ||||||||
Cash | 29,891,504 | 31,255,995 | 32,550,783 | |||||
Long term investments | 6,488,894 | 9,476,836 | 10,091,593 | |||||
Excess cash | 35,412,854 | 39,670,230 | 41,624,656 | |||||
Stockholders' equity | (38,510,667) | (21,275,000) | (17,573,624) | |||||
Invested Capital | 103,561,262 | 104,394,999 | 81,821,546 | |||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 63,551 | 62,635 | 61,751 | |||||
Price | 7,990.00 -47.61% | 15,250.00 -14.33% | 17,800.00 73.66% | |||||
Market cap | 507,770,453 -46.84% | 955,189,057 -13.10% | 1,099,163,955 75.25% | |||||
EV | 476,019,988 | 940,667,288 | 1,060,421,583 | |||||
EBITDA | (2,236,947) | (2,851,568) | (2,314,045) | |||||
EV/EBITDA | ||||||||
Interest | 1,147,128 | 1,723,710 | 750,694 | |||||
Interest/NOPBT | ||||||||